Skip to main content
Caplight Logo









Koodos

Koodos

Overview

Koodos is a UK-based, FCA-regulated strategic advisory and venture capital firm that invests in and supports early-stage companies in the healthcare, life sciences, and oncology sectors.

Year Founded

2023

Portfolio Companies

2

Investments

Koodos investments
CompanyDateStageLead
2cureXApr 2026Private PlacementCo-investor
PreComb TherapeuticsDec 2024Series ALead

Key People

Iain Hubert

Co-Founder

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Koodos based?

Koodos is headquartered in London, United Kingdom.

When was Koodos founded?

Koodos was founded in 2023.

How many portfolio companies does Koodos have?

Koodos has 2 portfolio companies in Caplight's dataset.

What are some companies in Koodos's portfolio?

Portfolio companies visible on Caplight include 2cureX, PreComb Therapeutics.

What was Koodos's most recent investment shown here?

Koodos's most recent investment in this portfolio sample was in 2cureX in 2026.

What sectors does Koodos focus on?

Koodos focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.

What company stages does Koodos focus on?

Stage focus information for Koodos is not publicly available.

Firmographic Details

HeadquartersLondon
Year Founded2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?